You searched for Wet AMD - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Showing results for: Wet AMD

31 May 2021

Novartis terminates Phase III trial of Beovu in AMD

Novartis has decided to terminate the two-year Phase III MERLIN clinical trial of Beovu (brolucizumab) in wet age-related macular degeneration (AMD) patients despite meeting the primary endpoint. Wet AMD develops…